Neurologic Outcome Predictors in Pediatric Intracerebral Hemorrhage: A Prospective Study

Giulia S Porcari1, Lauren A Beslow, Rebecca N Ichord

  • 1From the Vanderbilt University School of Medicine, Nashville, TN (G.S.P.).

Stroke
|June 14, 2018
PubMed

Insights

Over a third of pediatric patients with intracerebral hemorrhage had significant disability at 2 years. Key predictors of poor neurological outcome include altered mental status and larger hemorrhage volume.

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Neurosurgery

Background:

  • Intracerebral hemorrhage is a significant cause of disability and death in children.
  • Understanding long-term outcomes and predictors is crucial for improving pediatric care.

Purpose of the Study:

  • To describe the neurological outcomes of pediatric intracerebral hemorrhage.
  • To identify predictors of 2-year neurological outcomes in children.

Main Methods:

  • Prospective enrollment of 69 children (29 days to 18 years) with intracerebral hemorrhage across 3 centers.
  • Exclusion of cases with trauma, tumors, or other specific hemorrhage types.
  • Assessment of neurological outcomes using the Pediatric Stroke Outcome Measure and neuroimaging for volume quantification.

Main Results:

  • Nine percent of children died during hospitalization; 98% of survivors had early and 94% had late follow-up (median 2.1 years).
  • Over one-third of survivors had significant disability (Pediatric Stroke Outcome Measure >2) at 2 years.
  • Altered mental status, hemorrhage volume (≥4% of total brain volume), and ICU length of stay independently predicted poor 2-year outcomes.

Conclusions:

  • Significant disability is common in pediatric intracerebral hemorrhage survivors at 2 years.
  • Improvements in sensorimotor function contributed to overall outcome recovery.
  • Early identification of high-risk patients based on clinical and imaging factors is essential for targeted interventions.
Abstract

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.9K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.4K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239